GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Veljan Denison Ltd

Veljan Denison: Dr. Suresh Akella Re-appointed Independent Director for 5 Years

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 03 Aug 2026, 01:54 PM IST  ·  BSE ID: 04cce6f2-4975-4a6b-97c5-619c155c80e2
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has chosen to keep an existing independent director for another five years, pending shareholder vote.
🤖 AI Summary
  • Dr. Suresh Akella re-appointed as Independent Director for a second five-year term.
  • The reappointment is effective from September 30, 2026, to September 29, 2031.
  • Board believes Dr. Akella meets independence criteria and his experience benefits the company.
  • Shareholder approval is required via a Special Resolution for the reappointment.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Director Term
five (5) years
Reappointment Start Date
30.09.2026
Reappointment End Date
29.09.2031
🏢 How This Affects the Company
📈
Business Impact
The continuity of an experienced independent director is a signal of stable governance, which can positively influence investor confidence.
💰
Financial Impact
No direct financial impact is immediately apparent from this management change.
⚙️
Operational Impact
The reappointment ensures continued oversight and strategic guidance from a director familiar with the company's operations.
⚠️
Risk Impact
Maintaining experienced leadership can mitigate governance-related risks, but the reappointment is subject to shareholder approval, introducing a minor procedural risk.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to vote via a Special Resolution to approve the reappointment of Dr. Suresh Akella.
👤
Who Is Affected
All shareholders will be affected as their vote determines the continuation of Dr. Suresh Akella's tenure as an Independent Director.
🔍
Management Signal
This signals management's intent to retain experienced leadership and maintain governance continuity.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Shareholder meeting for Special Resolution approval.
Announcement of Dr. Suresh Akella's reappointment outcome.
Next quarterly financial results disclosure.
LOW RISK The filing concerns a standard director reappointment subject to shareholder vote.
💡 Investor Takeaway
Veljan Denison's Board has approved Dr. Suresh Akella's re-appointment as Independent Director for a second five-year term, commencing September 30, 2026, pending shareholder approval.
❓ Frequently Asked Questions
Who has Veljan Denison approved for re-appointment as Independent Director?
Veljan Denison has approved the re-appointment of Dr. Suresh Akella as an Independent Director.
For how long has Dr. Suresh Akella been re-appointed as Independent Director?
Dr. Suresh Akella has been re-appointed for a second consecutive term of five (5) years.
When is Dr. Suresh Akella's re-appointment as Independent Director effective?
The re-appointment is effective from 30.09.2026 and will end on 29.09.2031, subject to shareholder approval.
Does Dr. Suresh Akella's re-appointment require shareholder approval?
Yes, the re-appointment is subject to the approval of the shareholders of the Company by way of a Special Resolution.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.